ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,197,150 | +8149.4% | 217,000 | +14366.7% | 1.24% | +7211.8% |
| Q1 2020 | $63,000 | -99.3% | 1,500 | -99.3% | 0.02% | -99.0% |
| Q4 2019 | $8,834,000 | +22.7% | 206,500 | +3.2% | 1.73% | -33.4% |
| Q3 2019 | $7,198,000 | +34.6% | 200,000 | 0.0% | 2.60% | +59.8% |
| Q2 2019 | $5,346,000 | -0.4% | 200,000 | 0.0% | 1.63% | +9.5% |
| Q1 2019 | $5,370,000 | +70.3% | 200,000 | +2.6% | 1.49% | +26.3% |
| Q4 2018 | $3,153,000 | -22.1% | 195,000 | 0.0% | 1.18% | +14.3% |
| Q3 2018 | $4,048,000 | – | 195,000 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |